Karolinska Development's portfolio company Pharmanest

New Post Public Reply Private Reply Replies (0) Message Board
News Desk 2018
50
Karolinska Development's portfolio company Pharmanest appoints new CEO

 

STOCKHOLM, May 21, 2018. Karolinska Development's portfolio company Pharmanest AB announces the appointment of Helena Jansson as new Chief Executive Officer. Helena is an experienced life science executive, with a proven track record of successful business development and commercialization of pharmaceutical products. She replaces Gunilla Lundmark, who leaves her position after seven years. 

Helena Jansson has long experience in the life science industry and a broad knowledge base with a focus on business development and commercialization of pharmaceutical portfolios. She has spent a substantial part of her career at Medivir AB, in positions such as Business Unit Director, Head of Supply Chain and Director Alliance Management.

In 2017, Pharmanest signed an outlicensing agreement with Gedeon Richter, a leading European pharmaceutical company within women's health. The agreement gives Gedeon Richter the marketing and sales rights to commercialize Pharmanest's first product SHACT (Short Acting Lidocaine) in Europe, Latin America and certain other markets. SHACT is a patented and proprietary formulation of lidocaine for mucosal topical pain relief, where the lead indication is the treatment of pain during intrauterine device ("IUD") placement.

For further information, please contact:

Viktor Drvota, CEO, Karolinska Development AB Phone: +46 73 982 52 02, e-mail: viktor.drvota@karolinskadevelopment.com

TO THE EDITORS

About Karolinska Development AB Karolinska Development AB (Nasdaq Stockholm: KDEV) is a Nordic life sciences investment company. The company focuses on identifying breakthrough medical innovations in the Nordic region that are developed by entrepreneurs and leadership teams. The Company invests in the creation and growth of companies that advance these assets into commercial products that are designed to make a difference to patients' lives while providing an attractive return on investment to shareholders.

Karolinska Development has access to world-class medical innovations at the Karolinska Institutet and other leading universities and research institutes in the Nordic region. The Company aims to build companies around scientists who are leaders in their fields, supported by experienced management teams and advisers, and co-funded by specialist international investors, to provide the greatest chance of success.

Karolinska Development has established a portfolio of nine companies targeting opportunities in innovative treatment for life-threatening or serious debilitating diseases.

The Company is led by an entrepreneurial team of investment professionals with a proven track record as company builders and with access to a strong global network.

For more information, please visit www.karolinskadevelopment.com

Attachment

Scroll down for more posts ▼

Top 10 Most Recent News Articles

Vusion Lands a 2,000-Store dm EdgeSense Rollout in Germany

Updated Category News Views 144

A drugstore shelf rarely gets anyone's pulse racing, but 2,000 of them wired into a live digital system is a serious retail deployment. Vusion has expanded its partnership with dm-drogerie markt to roll out its newest EdgeSense platform across about 2,000 German stores over the next three years. This is not a glossy one-store pilot with a ribbon-cutting and a few tablets...

Continue Reading
LAFC Turns Empty Seats Into an AI Test Case for Sports

Updated Category News Views 151

Empty seats are a lousy kind of inventory A vacant stadium seat is perishable inventory with the clock screaming at it. LAFC and AccelerAI have aimed their first co-developed AI project at that unglamorous but important problem: getting more ticket holders through the gate without simply hacking prices down at the last minute. That is a far more sensible use of artificial...

Continue Reading
MIND Takes Its Copilot Security Bet Across Microsoft 365

Updated Category News Views 0

Copilot’s promise gets a lot less charming the minute confidential files start wandering around unchecked. That is the knot MIND is trying to untie with its expanded, generally available integrations across Microsoft Copilot, Microsoft 365, Purview, Teams, SharePoint, OneDrive, Edge and Exchange. The Seattle data-loss-prevention company announced the collaboration on...

Continue Reading
CJ BIO Bets on Better Taste for Cleaner Food Labels

Updated Category News Views 55

A bland reduced-salt sauce can wreck months of product development in one spoonful. That unglamorous reality sits underneath CJ BIO's November 17-19 appearance at Fi Europe 2026 in Frankfurt, where the company is pitching food makers on a simple but stubborn proposition: healthier-looking labels cannot come at the expense of taste. Flavor Is Still the Gatekeeper CJ BIO is...

Continue Reading
Wallstreet Sand Hands Its Massive Permian Plant to Wilbanks

Updated Category News Views 41

A sand plant can brag about acreage and horsepower all day, but frac crews remember who kept material arriving when a completion schedule got ugly. That is the real backdrop to PI Holdings and Wallstreet Sand Co. naming Blaine Wilbanks president of both businesses on November 18, 2026. This is not a ceremonial chair swap. Wallstreet has built an enormous Permian sand...

Continue Reading
Concierto's Azure Push Puts Sovereignty on Display

Updated Category News Views 117

Sovereignty has become the corporate cloud world's favorite hard-edged word. Concierto is taking that word straight onto the Microsoft Ignite 2026 floor, and frankly, it is a sensible place to make the case. The company, part of Trianz, will appear as a Gamechanger Sponsor from November 17 through 20 at San Francisco's Moscone Center, showing its platform at Booth #5435....

Continue Reading
Vusion's 2030 Plan Puts Recurring Revenue First At Scale

Updated Category News Views 30

Shelf labels are not exactly romance, yet Vusion has turned them into a serious growth machine. The 2030 plan is not really about hanging more electronic displays in aisles; it is about making those displays, sensors and store connections produce software and service revenue for years. That is the part of this story worth watching. The Hardware Base Is Becoming the Hook...

Continue Reading
Fapon’s Enzyme Push Meets Diagnostics Reality at AMP

Updated Category News Views 65

Enzymes rarely get applause at industry meetings, but they can quietly decide whether a diagnostic workflow behaves or becomes a lab headache. Fapon used its AMP 2026 appearance in Seattle to make that unglamorous case: better enzyme design may help assays move faster and keep working when samples get messy. The company wrapped up the November 10–14 meeting after...

Continue Reading
Hisense Year-End Push Tests Its Connected-Home Pitch

Updated Category News Views 45

A 300-inch picture is one heck of a way to sell a refrigerator. Hisense is rolling out year-end offers across the Middle East and Africa that stitch together its premium displays, connected appliances and ConnectLife software under one big household-upgrade pitch. It is glossy stuff, sure, but there is a practical commercial question underneath all the sparkle: can the...

Continue Reading
ZAKSIMLAB Tests Kombucha and Salmon Snack Pairing in Cafes

Updated Category News Views 171

A fish-based chip beside a fizzy tea mix is an odd little commercial wager, and that is exactly why ZAKSIMLAB's latest move deserves a look. The Seoul food brand launched Salmon Crunch Protein Chips in September, then put the snack next to its powdered kombucha at the 2026 Cafe & Bakery Fair Season 2. This is not a grand earnings story; no sales, pricing, store-count, or...

Continue Reading

Top 5 Most Recently Viewed Articles

HydrogenPro ASA Reports Strong Q4 2024 Financial Insights

Updated Category News Views 205

HydrogenPro ASA's Financial Results Overview HydrogenPro ASA (OSE: HYPRO) recently revealed its remarkable financial outcomes for the fourth quarter of 2024, showcasing a solid performance despite the challenges faced in the industry. This quarter highlights the company’s resilience and strengthens its position in the global hydrogen market. Key Achievements in Q4 2024...

Continue Reading
Angioplasty Balloons Market: $3.6B by 2033? Unpack the Growth!

Updated Category News Views 174

February 18, 2026—mark it down: the angioplasty balloons market is gearing up to swell from a cool $2.6 billion in 2023 to a whopping $3.6 billion by 2033 at a steady CAGR of 3.4%. Why? Well, take your pick: rising cardiovascular disease prevalence, a geriatric boom, and increasingly tech-savvy procedures are all fueling this surge. What’s Pumping Up Growth?...

Continue Reading
Norges Bank Transitions to Major Shareholder in NKT A/S

Updated Category News Views 175

Significant Shareholding Changes in NKT A/S In a recent announcement that has stirred interest in the investment community, it has come to light that Norges Bank has increased its holdings in NKT A/S. This announcement is significant as it illustrates the dynamic changes within major shareholding structures in public companies. Understanding the Acquisition NKT A/S has...

Continue Reading
Novo Nordisk Strengthens Shareholder Value with Buyback Plan

Updated Category News Views 103

Introduction to Novo Nordisk's Share Repurchase Program Leading healthcare company Novo Nordisk has embarked on an ambitious share repurchase program to strengthen its shareholder value. This initiative, aligning with European financial regulations, showcases the company's commitment to enhancing shareholder returns. The overall plan involves a substantial repurchase...

Continue Reading
Unlocking Potential: Monthly Dividend Strategies for Retirement

Updated Category News Views 189

Maximizing Monthly Income for Retirement Imagine enjoying monthly dividends that accumulate annual yields ranging from 7.2% to 15.4%. It’s enticing, especially for those looking for a steady stream of income during retirement. With the current market filled with uncertainty, many investors are skittish and hesitant to put their money into traditional investments. This...

Continue Reading